Fund moves
5.5%Stake
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
GDRX · NASDAQ · Services-Computer Processing & Data Preparation
Goodrx Holdings (GDRX) · oqro.io/stocks/GDRX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$2.92−0.10 (−3.31%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
No open-market purchase by an insider of Goodrx Holdings was filed in the last 90 days. The latest on record was on Nov 30, 2023.
Since 2020, Goodrx Holdings insiders reported 44 open-market purchases and 229 sales on Forms 4 and 5, with purchases in 2 different years, most recently 2023.
In the last 90 days, 1 insider of Goodrx Holdings (GDRX) reported 14 open-market sales worth $9.68M in total on SEC Form 4. The largest seller by value was FRANCISCO PARTNERS IV, with $9.68M. Many insider sales follow a plan set in advance or cover taxes on stock awards; the filing says what was sold, not the reason.
No trade in Goodrx Holdings (GDRX) was disclosed by a member of Congress in the last 12 months.
Goodrx Holdings's next results are expected on Feb 23, 2027, after the market closes. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
+11.5% (+$0.30) from Nov 20, 2025 to Nov 20, 2026 · adjusted daily closes
Adjusted close went from $2.62 on Nov 20, 2025 to $2.92 on Nov 20, 2026 (+11.5%). Disclosed in this range: 14 insider trades, 0 pre-arranged insider sales, 0 Congress trades.
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Services-Computer Processing & Data Preparation company based in Santa Monica, Ca.
Last 12 months
+12.3%
Market value
$1.03B
S&P 500 +8.0% over the same dates. Prices adjusted for splits and dividends.
Short interest: 3.57M shares sold short (1.0% of shares outstanding), −2.7% vs the previous count, 3.0 days of normal trading to buy them back. FINRA, as of Oct 30, 2026. Short interest history
Revenue, fiscal 2025
$797M
+0.6% vs the year before
Net income, fiscal 2025
$30.4M
As reported in the annual filing
Shares outstanding
341M
As of Jul 28, 2026
In fiscal 2025 the company spent $216M buying back its own shares. Cash actually paid, from its cash-flow statement.
Fund moves
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Traded Aug 26, 2026 · largest single transaction ~$1.54MNot reported under a pre-arranged trading plan
Aug 26, 2026~$1.54M · 439K sh @ $3.50
DetailsOfficial recordAug 26, 2026~$1.52M · 433K sh @ $3.50
DetailsOfficial recordAug 26, 2026~$750K · 213K sh @ $3.51
DetailsOfficial recordPrices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Revenue
$200M
−1.3% vs the same quarter a year earlier
Free cash flow, last 12 months
$197M
This quarter $80.5M, a year earlier $49.2M
Net debt
$190M
Debt $487M, cash $296M, at Jun 30, 2026
Net income, last 12 months
$16.2M
Operating profit covers interest 1.84x
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Aug 5, 2026.
Revenue and earnings history, 8 fiscal yearsRevenue breakdown: where the money goesCompared with its peersEarnings dates and the stock's moves
Aug 26, 2026~$739K · 210K sh @ $3.51
Said its annual or quarterly report would be late
“GoodRx Holdings, Inc. (the “Company”) is unable to file its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2026 (the “Form 10-Q”) within the prescribed time period without unreasonable effort or expense. As disclosed in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on November 2, 2026, the Company has concluded that its condensed consolidated fi”
NT 10-Q on sec.govPast financial statements can no longer be relied on
8-K on sec.govTop officer leaving
“Clark’s departure, the Board determined to move Wendy Barnes, Chief Executive Officer, President and Director of the Company, from Class I, with a term expiring at the 2027 annual meeting of stockholders, to Class III, with a term expiring at the 2026 annual meeting of stockholders.”
8-K on sec.govTop officer leaving
“Chief Accounting Officer Resignation On March 24, 2026, Romin Nabiey submitted his resignation as Chief Accounting Officer of GoodRx Holdings, Inc.”
8-K on sec.govChanged auditor
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.
Insiders of Goodrx Holdings reported 44 open-market purchases and 229 sales since 2020; purchases in 2 different years, most recently 2023.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $9.68M14×14 trades |
| 2025 | — | $255K8×8 trades |
| 2024 | — | $619K3×3 trades |
| 2023 | $982K5×5 trades | — |
| 2022 | — | $1.25M3×3 trades |
| 2021 | $60M39×39 trades | $358M196×196 trades |
| 2020 | — | $356M5×5 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Against the S&P 500 over the year
Since Nov 18, 2025, GDRX is up 4.7% and the index fund is up 4.5%: about the same. Traders call a stock that beats the index over a period a relative-strength leader.
How much GDRX moves
Beta 1.4 (1 year vs SPY)
End-of-day prices. These figures describe the past year and say nothing about what comes next. Beta: how much the stock moved, on average, for each 1% move of the S&P 500 fund over 249 trading days (1 = in step with it).
Source: SEC Schedules 13D and 13G, which anyone owning more than 5% of a class of stock must file. A 13D filer may seek to influence the company; a 13G filer is passive. Filings before December 2024 are free text and read from their cover page: a percent or share count that is not stated plainly is left blank. Each line links to the filing.
Written by OQRO's software from the last 12 months on record · Nov 19, 2026
Every number, name, date and link in the text above comes from this list; software checks that before the text is stored. This text was assembled directly from the facts, without a language model.
Insiders
Funds and stakes
Contracts, lobbying and filings
Company reports, price and press
Who holds it
Things to keep in mind
7 certified in FY2026 Q3, vs 5 a year earlier. 7 positions in total, median offered wage $173K a year.
Labor condition applications for H-1B workers certified by the Department of Labor, counted by decision date (FY2026 Q3: Apr 1, 2026 to Jun 30, 2026, the latest quarter published). A certified application is a step before a visa petition, not a hire or a visa, and one application can cover several positions. Matched by employer ID number or name.
Latest annual report filed Feb 26, 2026, compared with the one filed Feb 27, 2025. Read the filing
All 71 risk factor headings match the year before, give or take wording.
The information required under this Item 3 is set forth in Note 13 within “Notes to Consolidated Financial Statements” included in Part IV, Item 15 of this report and is incorporated herein by this reference.
The company describes its cases in the notes to its financial statements, in the same filing.
Source: SEC EDGAR, Form 10-K filed Feb 26, 2026. Headings are the titles the company gives each risk; OQRO compares them with the year before by their words, so a heading that was reworded a lot shows up as both new and no longer listed. Companies list the risks they face, not forecasts.
Off-exchange trading: 32.9% of the shares traded over the latest 4 published weeks changed hands away from the exchanges (17.8% on ATS, 15.1% with other brokers), below its 26-week average of 43.6%. Weeks of Sep 21 to Oct 16, 2026.
Largest ATS: MS POOL (ATS-4) (16.3%), MS TRAJECTORY CROSS (ATS-1) (13.3%), INTELLIGENT CROSS LLC (13.2%), as a share of this stock's ATS volume over the same 4 weeks.
An ATS, often called a dark pool, is a private trading venue run by a broker where orders are not shown publicly before they trade. Other off-exchange trades are mostly retail orders filled by wholesale brokers. A high share is common and says nothing by itself about where the price goes. FINRA OTC Transparency data, published 2 weeks after each week for the largest stocks and 4 weeks for others; total volume from our daily price data.
The three months Apr 1, 2026 to Jun 30, 2026, compared with the same quarter a year earlier, from the quarterly report filed Aug 5, 2026. Quarterly reports are not audited. Read the filing
−26% on the same quarter a year earlier ($143M)
+76% on the same quarter a year earlier ($35M)
+39% on the same quarter a year earlier ($20.5M)
−15% on the same quarter a year earlier ($4.56M)
Fiscal year Jan 1, 2025 to Dec 31, 2025, from the annual report filed Feb 26, 2026. Read the filing
−5.8% on the year before ($578M)
+41% on the year before ($107M)
−3.2% on the year before ($86.5M)
−16% on the year before ($21M)
Every annual report has a section where the company's managers explain the year's results (Item 7, Management's discussion and analysis). In this report it runs to about 5,000 words.
Our mission is to help Americans save time and money when filling their medications. To achieve this, we are building the leading consumer-focused digital healthcare platform in the United States. For example, during 2025, we announced the launch of our first condition-specific subscription program for erectile dysfunction and continued to expand to other conditions including hair loss and weight loss. Certain of these condition-specific subscription programs offer consumers a single solution for comprehensive care by bundling the clinician visit, prescription (if deemed medically appropriate by the treating healthcare provider), and related delivery for a single total subscription price.
And 16 more headings in the filing.
Source: SEC EDGAR, Form 10-K filed Feb 26, 2026 and Form 10-Q filed Aug 5, 2026. Revenue lines are the figures the company tags in its filing; OQRO shows a split only when its lines add up to the reported total revenue. The quote is the opening of the managers' discussion, cut at a sentence; the word count is estimated from its length. Not investment advice.
Last results
Aug 5, 2026
More than 30 days ago
Next results, expected
Nov 23, 2026
before the market opens; the date can move until the company confirms it
Purchases after results
100%
44 of 44 insider purchases since 2020 came within 30 days after a results announcement
From Goodrx Holdings's own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know Goodrx Holdings's policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.